- Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details – should you subscribe?  livemint.com
- CORONA Remedies IPO: Should you apply?  Value Research
- Corona Remedies IPO Day 1 LIVE: Issue opens today. GMP, subscription status, review, other key things. Apply or not?  livemint.com
- Is Corona Remedies’ IPO a compelling bet for long-term wealth creation?  The Economic Times
- Corona Remedies raises nearly Rs 195 crore from 15 anchor investors ahead of Rs 655-crore IPOÂ Â Moneycontrol
​Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details – should you subscribe?  livemint.comCORONA Remedies IPO: Should you apply?  Value ResearchCorona Remedies IPO Day 1 LIVE: Issue opens today. GMP, subscription status, review, other key things. Apply or not?  livemint.comIs Corona Remedies’ IPO a compelling bet for long-term wealth creation?  The Economic TimesCorona Remedies raises nearly Rs 195 crore from 15 anchor investors ahead of Rs 655-crore IPO  Moneycontrol by Soban News (international And National News)